Cited by 740Alcohol Consumption and Health EffectsSubstance Abuse Treatment and OutcomesGlobal Public Health Policies and Epidemiology

The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.

Global burden of alcoholic liver diseases

Open access

Rehm, Jürgen, Samokhvalov, Andriy V., Shield, Kevin D.·2013·Journal of Hepatology

DOI 10.1016/j.jhep.2013.03.007

Open this paper in CoChat — free account

Abstract

Liver diseases contribute markedly to the global burden of mortality and disease. This paper provides an overview from a global perspective of the contribution of alcohol to liver diseases. The Global Burden of Disease study methodology was used to estimate the burden of alcohol-attributable liver cirrhosis and alcohol-attributable liver cancer in 2010 as measured by deaths and disability adjusted life years (DALYs). This methodology estimates attributable fractions based on alcohol exposure distribution and relative risks associated with different levels of drinking. Globally, in 2010, alcohol-attributable liver cirrhosis was responsible for 493,300 deaths (156,900 female deaths and 336,400 male deaths) and 14,544,000 DALYs (4,112,000 DALYs for women and 10,432,000 DALYs for men), representing 0.9% (0.7% for women and 1.2% for men) of all global deaths and 0.6% (0.4% for women and 0.8% for men) of all global DALYs, and 47.9% of all liver cirrhosis deaths (46.5% for women and 48.5% for men) and 46.9% of all liver cirrhosis DALYs (44.5% for women and 47.9% for men). Alcohol-attributable liver cancer was responsible for 80,600 deaths (14,800 female deaths and 65,900 male deaths) and 2,142,000 DALYs (335,000 DALYs for women and 1,807,000 DALYs for men). The burden of alcohol-attributable liver cirrhosis and liver cancer is high and entirely preventable. Interventions to reduce alcohol consumption are recommended as a population health priority and may range from taxation increases for alcoholic beverages to increases in screening and treatment rates for alcohol use disorders.

Integrity signals

Registry

Crossref · 10.1016/j.jhep.2013.03.007

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
Lim, S. S., Vos, T., Flaxman, A. D., Danaei, G., Shibuya, K., Adair-Rohani, H., AlMazroa, M. A., Amann, M., Anderson, H. R., Andrews, K. G., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61766-8 · Cited by 11,805
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010
Murray, C. J. L., Vos, T., Lozano, R., Naghavi, M., Flaxman, A. D., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61689-4 · Cited by 8,888
Global status report on noncommunicable diseases 2010.
Alwan, A. (2011) · Cited by 8,494
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
Vos, T., Flaxman, A. D., Naghavi, M., Lozano, R., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., Aboyans, V., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61729-2 · Cited by 8,291
Comparative quantification of health risks : global and regional burden of disease attributable to selected major risk factors
Ezzati, M., López, A. D., Rodgers, A., & Murray, C. J. L. (2004) · Cited by 3,319
Global Burden of Disease and Risk Factors
López, A. D., Mathers, C. D., Ezzati, M., Jamison, D. T. T., & Murray, C. J. L. (2006) · World Bank, Washington, DC eBooks · doi:10.1596/978-0-8213-6262-4 · Cited by 2,714
Alcohol: No Ordinary Commodity. Research and public policy
Babor, T. F., Caetano, R., Casswell, S., Edwards, G., Giesbrecht, N., Graham, K., Grube, J. W., Hill, L., Holder, H. D., Homel, R. J., et al. (2003) · Cited by 1,718
Self-citation
Use and misuse of population attributable fractions
Rockhill, B., Newman, B., & Weinberg, C. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.1.15 · Cited by 1,683
Nonalcoholic fatty liver disease
Adams, L. A. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.045232 · Cited by 1,658

Show all 59 references

Research works printed but not linked: 1

Kehoe, 2012, Determining the best population-level alcohol consumption model and its impact on estimates of alcohol-attributable harms, Popul Health Metrics, 10, 6, 10.1186/1478-7954-10-6 · DOI · Paper page

Sorted by citations

Items 301–400 of 738

Off‐premise alcohol purchasing in Australia: Variations by age group, income level and annual amount purchased
Jiang, H., Callinan, S., Livingston, M., & Room, R. (2016) · Drug and Alcohol Review · doi:10.1111/dar.12402 · Cited by 24
Quantifying the global contribution of alcohol consumption to cardiomyopathy
Manthey, J., Imtiaz, S., Neufeld, M., Rylett, M., & Rehm, J. T. (2017) · Population Health Metrics · doi:10.1186/s12963-017-0137-1 · Cited by 24
Self-citation
An iso-α-acid-rich extract from hops ( Humulus lupulus ) attenuates acute alcohol-induced liver steatosis in mice
Hege, M., Jung, F., Sellmann, C., Jin, C., Ziegenhardt, D., Hellerbrand, C., & Bergheim, I. (2017) · Nutrition · doi:10.1016/j.nut.2017.07.010 · Cited by 25
Interaction between the patatin‐like phospholipase domain‐containing protein 3 genotype and coffee drinking and the risk for acute alcoholic hepatitis
Liangpunsakul, S., Beaudoin, J. J., Shah, V. H., Puri, P., Sanyal, A. J., Kamath, P. S., Lourens, S. G., Tang, Q., Katz, B. P., Crabb, D. W., et al. (2017) · Hepatology Communications · doi:10.1002/hep4.1123 · Cited by 24
Ademetionine in patients with liver disease: a review
Saigal, S., Kapoor, D., & Roy, D. S. (2019) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20192550 · Cited by 23
Effects of compound Ginkgo biloba on intestinal permeability in rats with alcohol-induced liver injury
Li, H., Qiu, P., Wang, J., Niu, C., & Suhua, P. (2014) · Food & Function · doi:10.1039/c4fo00739e · Cited by 23
Genetic Loss of Immunoglobulin A Does Not Influence Development of Alcoholic Steatohepatitis in Mice
Inamine, T., Yang, A., Wang, L., Lee, K., Llorente, C., & Schnabl, B. (2016) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13239 · Cited by 23
Adipose tissue autophagy and homeostasis in alcohol-induced liver injury
Li, Y., & Ding, W. (2017) · Liver Research · doi:10.1016/j.livres.2017.03.004 · Cited by 23
Where should the safe limits of alcohol consumption stand in light of liver enzyme abnormalities in alcohol consumers?
Niemelä, O. J., Niemelä, M., Bloigu, R., Aalto, M., & Laatikainen, T. K. (2017) · PLoS ONE · doi:10.1371/journal.pone.0188574 · Cited by 25
Quercetin ameliorates autophagy in alcohol liver disease associated with lysosome through mTOR-TFEB pathway
Li, Y., Chen, M., Wang, J., Guo, X., Xiao, L., Liu, P., Liu, L., Tang, Y., & Yao, P. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.10.033 · Cited by 23
Patterns of drinking and liver cirrhosis – What do we know and where do we go?
Rehm, J., & Roerecke, M. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.01.027 · Cited by 22
Self-citation
Multidisciplinary Care of Alcohol-related Liver Disease and Alcohol Use Disorder: A Narrative Review for Hepatology and Addiction Clinicians
Shroff, H., & Gallagher, H. (2023) · Clinical Therapeutics · doi:10.1016/j.clinthera.2023.09.016 · Cited by 23
Beyond the Liver: A Comprehensive Review of Strategies to Prevent Hepatocellular Carcinoma
Polpichai, N., Saowapa, S., Danpanichkul, P., Chan, S., Sierra, L., Blagoie, J., Rattananukrom, C., Sripongpun, P., & Kaewdech, A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13226770 · Cited by 25
Elafibranor interrupts adipose dysfunction-mediated gut and liver injury in mice with alcoholic steatohepatitis
Li, T., Yang, Y.-Y., Huang, C., Liu, C.-W., Tsai, H., Lin, M., Tsai, C., Huang, S., Wang, Y.-W., Lee, T.-Y., et al. (2019) · Clinical Science · doi:10.1042/cs20180873 · Cited by 22
Alcohol associated liver cirrhotics have higher mortality after index hospitalization: Long-term data of 5,138 patients
Jain, P., Shasthry, S. M., Choudhury, A. K., Maiwall, R., Kumar, G., Bharadwaj, A., Arora, V., Vijayaraghavan, R., Jindal, A., Sharma, M. K., et al. (2020) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2020.0068 · Cited by 23
Alcohol produces distinct hepatic lipidome and eicosanoid signature in lean and obese
Puri, P., Xu, J., Vihervaara, T., Katainen, R., Ekroos, K., Daita, K., Min, H., Joyce, A., Mirshahi, F., Tsukamoto, H., et al. (2016) · Journal of Lipid Research · doi:10.1194/jlr.m066175 · Cited by 22
Alcohol use disorders in Australia
Freyer, C. H., Morley, K. C., & Haber, P. (2016) · Internal Medicine Journal · doi:10.1111/imj.13237 · Cited by 22
Intracellular hepatitis B virus increases hepatic cholesterol deposition in alcoholic fatty liver via hepatitis B core protein
Wang, Y., Wu, T., Hu, D., Weng, X., Wang, X., Chen, P., Luo, X., Wang, H., & Ning, Q. (2017) · Journal of Lipid Research · doi:10.1194/jlr.m079533 · Cited by 22
A Model to Identify Heavy Drinkers at High Risk for Liver Disease Progression
Delacôte, C., Bauvin, P., Louvet, A., Dautrecque, F., Wandji, L. C. N., Lassailly, G., Voican, C. S., Perlemuter, G., Naveau, S., Mathurin, P., et al. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.12.041 · Cited by 22
New Developments in Microbiome in Alcohol-Associated and Nonalcoholic Fatty Liver Disease
Hartmann, P., & Schnabl, B. (2021) · Seminars in Liver Disease · doi:10.1055/s-0040-1719174 · Cited by 22
Laboratory test based assessment of WHO alcohol risk drinking levels
Niemelä, O. J., Nivukoski, U., Bloigu, A. H., Bloigu, R., Aalto, M., & Laatikainen, T. K. (2019) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365513.2019.1571625 · Cited by 22
The Beneficial Effects of Natural Extracts and Bioactive Compounds on the Gut-Liver Axis: A Promising Intervention for Alcoholic Liver Disease
Zhao, L., Wang, S., Zhang, N., Zhou, J., Mehmood, A., Raka, R. N., Zhou, F. L., & Zhao, L. (2022) · Antioxidants · doi:10.3390/antiox11061211 · Cited by 23
Current Therapeutic Options and Potential of Mesenchymal Stem Cell Therapy for Alcoholic Liver Disease
Han, J., Lee, C., Hur, J., & Jung, Y. (2022) · Cells · doi:10.3390/cells12010022 · Cited by 21
Alcoholic Hepatitis: Risk Factors, Pathogenesis, and Approach to Treatment
Yeluru, A., Cuthbert, J. A., Casey, L. C., & Mitchell, M. C. (2016) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12956 · Cited by 21
RORα switches transcriptional mode of ERRγ that results in transcriptional repression of CYP2E1 under ethanol-exposure
Han, Y., Kim, D., Na, T., Ka, N., Choi, H., & Lee, M. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1034 · Cited by 21
The Effects of Alcohol Use on Economic Decision Making
Bregu, K., DECK, C. A., Ham, L. S., & Jahedi, S. (2017) · Southern Economic Journal · doi:10.1002/soej.12179 · Cited by 21
Fatty liver index as a predictor of increased risk of cardiometabolic disease: finding from the Kuopio Ischaemic Heart Disease Risk Factor Study Cohort
Olubamwo, O., Virtanen, J. K., Pihlajamäki, J., Mäntyselkä, P. T., & Tuomainen, T. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-031420 · Cited by 21
Moderate Alcoholic Hepatitis
Clemente, A. P. G., Oliveira-Mello, A., & Bataller, R. A. (2021) · Clinics in Liver Disease · doi:10.1016/j.cld.2021.03.001 · Cited by 21
Incidence and implications of abstinence-induced recompensation in alcohol-related cirrhosis
Hofer, B., Tonon, M., Buttler, L., Neves, J. C., Herms, Q., Pompili, E., Ignat, M. D., Métivier, S., Rodrigues, S. G., Gutmann, D., et al. (2026) · Journal of Hepatology · doi:10.1016/j.jhep.2026.01.007 · Cited by 20
Liver enzymes in alcohol consumers with or without binge drinking
Nivukoski, U., Bloigu, A. H., Bloigu, R., Aalto, M., Laatikainen, T. K., & Niemelä, O. J. (2019) · Alcohol · doi:10.1016/j.alcohol.2019.03.001 · Cited by 20
ALDH2 genotype modulates the association between alcohol consumption and AST/ALT ratio among middle-aged Japanese men: a genome-wide G × E interaction analysis
Sutoh, Y., Hachiya, T., Suzuki, Y., Komaki, S., Ohmomo, H., Kakisaka, K., Wang, T., Takikawa, Y., & Shimizu, A. (2020) · Scientific Reports · doi:10.1038/s41598-020-73263-1 · Cited by 21
Molecular mechanisms of alcohol's effects on the human body: A review and update
Renu, K., Myakala, H., Chakraborty, R., Bhattacharya, S., Abuwani, A. M., Lokhandwala, M., Vellingiri, B., & Gopalakrishnan, A. V. (2023) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23502 · Cited by 20
The Interplay between Alcoholic Liver Disease, Obesity, and the Metabolic Syndrome
Malnick, S. D. H., & Maor, Y. (2020) · Visceral Medicine · doi:10.1159/000507233 · Cited by 20
GanMeijian ameliorates lipid accumulation and oxidative damage in alcoholic fatty liver disease in Wistar rats
Li, Y., Sun, Y., Zang, Y., Su, Y.-T., Zhou, H., Wang, J., Xie, M., Chen, G., Liu, L., & Mei, Q. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117721 · Cited by 20
The Role of Epigenetic Changes in the Progression of Alcoholic Steatohepatitis
Kim, H.-G., Cho, J.-H., Kim, J., & Kim, S.-J. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.691738 · Cited by 20
Camel milk ameliorates inflammatory mechanisms in an alcohol-induced liver injury mouse model
Ming, L., Qi, B., Hao, S., & Ji, R. (2021) · Scientific Reports · doi:10.1038/s41598-021-02357-1 · Cited by 20
Utility of Platelet Count for Predicting Cirrhosis in Alcoholic Liver Disease: Model for Identifying Cirrhosis in a US Population
Murali, A. R., Attar, B. M., Katz, A., Kotwal, V. S., & Clarke, P. M. (2015) · Journal of General Internal Medicine · doi:10.1007/s11606-015-3238-1 · Cited by 20
Contribution of high body mass index and alcohol use to liver cancer-related mortality: A study based on 195 countries or territories
Zhang, G., Cao, F., Shi, L., Ma, T., & Zhang, L. (2019) · Digestive and Liver Disease · doi:10.1016/j.dld.2019.10.012 · Cited by 19
Role of alcohol in the development and progression of hepatocellular carcinoma
McKillop, I. H., Schrum, L. W., & Thompson, K. J. (2015) · Hepatic Oncology · doi:10.2217/hep.15.40 · Cited by 18
Management of Alcohol Misuse in Patients with Liver Diseases
Peng, J. L., Patel, M., McGee, B., Liang, T., Chandler, K., Tayarachakul, S., O’Connor, S., & Liangpunsakul, S. (2016) · Journal of Investigative Medicine · doi:10.1136/jim-2016-000254 · Cited by 19
Living Donor Liver Transplant for Alcoholic Liver Disease: Data from the Adult-to-adult Living Donor Liver Transplantation Study
Braun, H. J., Dodge, J. L., Grab, J. D., Syed, S. M., Roll, G. R., Freise, C. E., Roberts, J. P., & Ascher, N. L. (2019) · Transplantation · doi:10.1097/tp.0000000000002783 · Cited by 19
Sphingolipids and the link between alcohol and cancer
Barron, K. A., Jeffries, K. A., & Krupenko, N. I. (2020) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2020.109058 · Cited by 19
Alcoholic Liver Disease and Liver Transplantation
Gallegos-Orozco, J. F., & Charlton, M. (2016) · Clinics in Liver Disease · doi:10.1016/j.cld.2016.02.009 · Cited by 19
Alcoholic Liver Disease
Mitchell, M. C., & Szabó, G. (2017) · Wiley eBooks · doi:10.1002/9781119251316.ch26 · Cited by 19
Urinary acrolein metabolite levels in severe acute alcoholic hepatitis patients
Vatsalya, V., Kong, M., Gobejishvili, L., Chen, W.-Y., Srivastava, S., Barve, S. S., McClain, C. J., & Joshi‐Barve, S. (2018) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00209.2018 · Cited by 18
Protective effects of whey on rat liver damage induced by chronic alcohol intake
Radić, I., Mijović, M., Tatalović, N., Mitić, M., Lukić, V., Joksimović, B., Petrovic, Z., Ristic, S., Veličković, S., Nestorović, V., et al. (2019) · Human & Experimental Toxicology · doi:10.1177/0960327119829518 · Cited by 18
Evolution of care in cirrhosis: Preventing hepatic decompensation through pharmacotherapy
Lee, S., & Saffo, S. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i1.61 · Cited by 22
The effect of selected Non-Saccharomyces yeasts and cold-contact fermentation on the production of low-alcohol marula fruit beer
Hlangwani, E., du Plessis, H. W., & Dlamini, B. C. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e24505 · Cited by 18
Liver transplantation for severe alcoholic hepatitis– The PRO view
Lucey, M. R. (2017) · Liver International · doi:10.1111/liv.13343 · Cited by 18
The Genetics of Clinical Liver Diseases: Insight into the TM6SF2 E167K Variant
Zhang, X., Liu, S., Dong, Q., Xin, Y., & Xuan, S. (2018) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2018.00022 · Cited by 18
In vivo Hepatoprotective and in vitro Radical Scavenging Activities of Extracts of Rumex abyssinicus Jacq. Rhizome
Adamu, B. A., Emiru, Y. K., Sintayehu, B., Araya, E. M., Periasamy, G., & Hiben, M. G. (2020) · Journal of Experimental Pharmacology · doi:10.2147/jep.s258566 · Cited by 18
The effects of Gentiana dahurica Fisch on alcoholic liver disease revealed by RNA sequencing
Cao, H., Xi, S.-Y., He, W., Ma, X., Liu, L., Xu, J., Zhang, K., Li, Y., & Jin, L. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113422 · Cited by 18
The interplay of Western diet and binge drinking on the onset, progression, and outlook of liver disease
Skinner, R. C., & Hagaman, J. A. (2021) · Nutrition Reviews · doi:10.1093/nutrit/nuab031 · Cited by 18
Sex and age differences in the early identification and treatment of alcohol use: a population‐based study of patients with alcoholic cirrhosis
Otete, H. E., Orton, E., West, J., & Fleming, K. M. (2015) · Addiction · doi:10.1111/add.13081 · Cited by 18
Burden of Alcohol‐Related Liver Disease and Alcohol Use Disorder in Asia
Danpanichkul, P., Pang, Y., Suparan, K., Saokhieo, P., Jatupornpakdee, P., Polpichai, N., Attachaipanich, T., Suenghataiphorn, T., Ibrahim, A., Vichitkunakorn, P., et al. (2025) · United European Gastroenterology Journal · doi:10.1002/ueg2.70077 · Cited by 17
Identification of an IRF–ZBP1–caspase-8–NINJ1 axis in driving PANoptosis and pathology during alcohol-associated liver disease
Qin, Q., Chen, W., King, C. D., Kumar, S. P., Farran, C. A. E., Vogel, P., Tweedell, R. E., & Kanneganti, T. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2525296122 · Cited by 25
Crosstalk between liver macrophages and gut microbiota: An important component of inflammation-associated liver diseases
Zhou, Z., Pan, X., & Li, L. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1070208 · Cited by 19
IgA nephropathy featuring massive wire loop-like deposits in two patients with alcoholic cirrhosis
Takada, D., Sumida, K., Sekine, A., Hazue, R., Yamanouchi, M., Suwabe, T., Hayami, N., Hoshino, J., Sawa, N., Takaichi, K., et al. (2017) · BMC Nephrology · doi:10.1186/s12882-017-0769-1 · Cited by 17
Open-label Study with Nalmefene as Needed Use in Alcohol-Dependent Patients with Evidence of Elevated Liver Stiffness and/or Hepatic Steatosis
Mueller, S., Luderer, M., Zhang, D., Meulien, D., Steiniger‐Brach, B., & Schou, M. B. (2019) · Alcohol and Alcoholism · doi:10.1093/alcalc/agz078 · Cited by 17
Beer Is Less Harmful for the Liver than Plain Ethanol: Studies in Male Mice Using a Binge-Drinking Model
Landmann, M., Wagnerberger, S., Kanuri, G., Ziegenhardt, D., & Bergheim, I. (2015) · Alcohol and Alcoholism · doi:10.1093/alcalc/agv048 · Cited by 17
Addiction specialist's role in liver transplantation procedures for alcoholic liver disease
Dom, G. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i17.2091 · Cited by 17
Targeted inhibition of pathobiont virulence factor mitigates alcohol-associated liver disease
Yang, Y., Duan, Y., Lang, S., Fondevila, M. F., Schöler, D., Harberts, A., Cabré, N., Chen, S., Shao, Y., Vervier, K., et al. (2025) · Cell Host & Microbe · doi:10.1016/j.chom.2025.05.003 · Cited by 16
Alcoholic hepatitis: Challenges in diagnosis and management
Dugum, M. F., Zein, N. N., McCullough, A. J., & Hanouneh, I. A. (2015) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.82a.14048 · Cited by 16
Efficacy of granulocyte colony stimulating factor in patients with severe alcoholic hepatitis with partial or null response to steroid (GRACIAH trial): study protocol for a randomized controlled trial
Cho, Y., Park, Y. S., Kim, H. Y., Kim, W. K., Lee, H. J., & Kim, D. J. (2018) · Trials · doi:10.1186/s13063-018-3092-7 · Cited by 16
Gut Microbiome-Centered Therapies for Alcohol-Associated Liver Disease
Ranjbarian, T., & Schnabl, B. (2023) · Seminars in Liver Disease · doi:10.1055/a-2145-7331 · Cited by 16
Brain GABA levels are reduced in alcoholic liver disease: A proton magnetic resonance spectroscopy study
Morley, K. C., Lagopoulos, J., Logge, W., Baillie, A., Adams, C., & Haber, P. (2018) · Addiction Biology · doi:10.1111/adb.12702 · Cited by 16
Significance of Markers of Monocyte Activation (CD163 and sCD14) and Inflammation (IL‐6) in Patients Admitted for Alcohol Use Disorder Treatment
García‐Calvo, X., Bolao, F., Sanvisens, A., Zuluaga, P., Tor, J., Muga, R., & Fuster, D. (2019) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14228 · Cited by 17
Accuracy of rule extraction using a recursive-rule extraction algorithm with continuous attributes combined with a sampling selection technique for the diagnosis of liver disease
Hayashi, Y., & Fukunaga, K. (2016) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2016.10.001 · Cited by 16
Characterization of an Inducible Alcoholic Liver Fibrosis Model for Hepatocellular Carcinoma Investigation in a Transgenic Porcine Tumorigenic Platform
Gaba, R. C., Mendoza-Elias, N., Regan, D. P., Garcia, K. D., Lokken, R. P., Schwind, R. M., Eichner, M., Thomas, F. M., Rund, L. A., Schook, L. B., et al. (2018) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2018.03.007 · Cited by 18
Effective Food Ingredients for Fatty Liver: Soy Protein β-Conglycinin and Fish Oil
Yamazaki, T., Li, D., & Ikaga, R. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19124107 · Cited by 16
Increased Prevalence of Obesity and Metabolic Syndrome in Patients with Alcoholic Fatty Liver Disease
Singh, A., Amin, H., Garg, R., Gupta, M., López, R., Alkhouri, N., & McCullough, A. J. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06056-1 · Cited by 16
Carotenoids Improve Obesity and Fatty Liver Disease via Gut Microbiota: A Narrative Review
Hashemi, D., Fard, M. V., Mohammadhasani, K., Barati, M., & Nattagh‐Eshtivani, E. (2025) · Food Science & Nutrition · doi:10.1002/fsn3.70092 · Cited by 15
Serum HMGB1 associates with liver disease and predicts readmission and mortality in patients with alcohol use disorder
Vannier, A., Wardwell, B., Fomin, V., PeBenito, A., Wolczynski, N., Piaker, S., Kedrin, D., Chung, R. T., Schaefer, E. A. K., Goodman, R. P., et al. (2021) · Alcohol · doi:10.1016/j.alcohol.2021.05.003 · Cited by 15
Gut microbiome in liver pathophysiology and cholestatic liver disease
Yan, S., & Yin, X. (2021) · Liver Research · doi:10.1016/j.livres.2021.08.001 · Cited by 16
Survival and risk factors related to death in outpatients with cirrhosis treated in a clinic in Southern Brazil
John, J. A., de Mattos, Â. A., Miozzo, S. A. D. S., Comerlato, P. H., Porto, M., Contiero, P., & da Silva, R. R. (2015) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000480 · Cited by 15
Cardiovascular Outcomes in Patients With Biopsy-proven Alcohol-related Liver Disease
Hagström, H., Thiele, M. S., Sharma, R., Simon, T. G., Roelstraete, B., Söderling, J. K., Sundström, J., & Ludvigsson, J. F. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2022.10.022 · Cited by 15
Acute Alcoholic Hepatitis, the Clinical Aspects
Dugum, M. F., & McCullough, A. J. (2016) · Clinics in Liver Disease · doi:10.1016/j.cld.2016.02.008 · Cited by 15
Collagen proportionate area correlates to hepatic venous pressure gradient in non-abstinent cirrhotic patients with alcoholic liver disease
Restellini, S., Goossens, N., Clément, S., Lanthier, N., Negro, F., Rubbia‐Brandt, L., & Spahr, L. (2018) · World Journal of Hepatology · doi:10.4254/wjh.v10.i1.73 · Cited by 15
Point Shear Wave Elastography for Non-invasive Assessment of Liver Fibrosis in Patients with Viral Hepatitis
Bucsics, T., Grasl, B., Ferlitsch, A., Schwabl, P., Mandorfer, M., Zinober, K., Stern, R., Chromy, D., Scheiner, B., Sieghart, W., et al. (2018) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2018.07.031 · Cited by 15
Metabolomic Analysis Uncovers Energy Supply Disturbance as an Underlying Mechanism of the Development of Alcohol‐Associated Liver Cirrhosis
Huang, Y., Niu, M., Jing, J., Zhang, Z.-T., Zhao, X., Chen, S., Li, S., Shi, Z., Huang, A., Zou, Z., et al. (2021) · Hepatology Communications · doi:10.1002/hep4.1699 · Cited by 15
Early Detection of Alcoholic Liver Disease: Are We a Step Closer?
Liangpunsakul, S., & Crabb, D. W. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.11.030 · Cited by 15
Probiotics in treating with alcoholic liver disease and nonalcoholic fatty liver disease
Liu, L., Wang, Y., Zhang, J., Wang, C., Li, Y., Dai, W., Piao, C., Liu, J., Yu, H., Li, X., et al. (2021) · Food Reviews International · doi:10.1080/87559129.2021.1967380 · Cited by 14
Focus on alcoholic liver disease: From nosography to treatment
Streba, L. A. M. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i25.8040 · Cited by 14
Estimation of utility weights for major liver diseases according to disease severity in Korea
Ock, M., Lim, S. Y., Lee, H., Kim, S., & Jo, M. (2017) · BMC Gastroenterology · doi:10.1186/s12876-017-0660-3 · Cited by 14
Rev-erbα exacerbates hepatic steatosis in alcoholic liver diseases through regulating autophagy
Liu, Q., Xu, L., Wu, M., Zhou, Y., Yang, J., Huang, C., Xu, T., Li, J., & Zhang, L. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00622-4 · Cited by 15
Sodium Butyrate Induces Hepatic Differentiation of Mesenchymal Stem Cells in 3D Collagen Scaffolds
Rashid, S., Salim, A., Qazi, R., Malick, T. S., & Haneef, K. (2022) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-022-03941-5 · Cited by 14
Intestinal ELF4 Deletion Exacerbates Alcoholic Liver Disease by Disrupting Gut Homeostasis
Liu, T., Yu, H., Zhang, Z., Xie, Y., Yang, L., & You, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094825 · Cited by 14
Involvement of Insulin Resistance in the Protective Effect of Metformin Against Alcoholic Liver Injury
Zhu, Z., Jiang, Z., Zhou, J., Zhou, D., Wang, W., Zhao, C., Zhen, Z., & Nanji, A. A. (2014) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12418 · Cited by 14
Longitudinal association of obesity, metabolic syndrome and diabetes with risk of elevated aminotransferase levels in a cohort of Mexican health workers
Flóres, Y. N., Auslander, A., Crespi, C. M., Rodriguez, M., Zhang, Z., Durazo, F. A., & Salmerón, J. (2016) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12341 · Cited by 16
Incidence, inhospital mortality, and readmission among patients with alcoholic hepatitis in Korea: A nationwide study
Lee, J. Y., Cho, Y., Hong, M. H., Kim, J., Lee, D. H., Jung, Y. J., Kim, B. G., Lee, K. L., & Kim, W. K. (2018) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14513 · Cited by 14
Current Management and Future Treatment of Alcoholic Hepatitis.
Mitchell, M. C., Kerr, T. A., & Herlong, H. F. (2020) · PubMed Central · Cited by 14
Impacts of smoking on alcoholic liver disease: a nationwide cohort study
Yoo, J., Lee, D. H., Kim, S. G., Jang, J. Y., Kim, Y. S., & Kim, L. Y. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1427131 · Cited by 14
Nutritional Status and Diet Style Affect Cognitive Function in Alcoholic Liver Disease
Choi, Y. R., Kim, H. S., Yoon, S. J., Lee, N. Y., Gupta, H., Ganesan, R., Gebru, Y. A., Youn, G. S., Kim, D. J., Ham, Y. L., et al. (2021) · Nutrients · doi:10.3390/nu13010185 · Cited by 16
The Prophylactic Effects of Glutamine on Muscle Protein Synthesis and Degradation in Rats with Ethanol-Induced Liver Damage
Xiao, Q., Chen, Y.-H., Pratama, S. A., Chen, Y.-L., Shirakawa, H., Peng, H.-C., & Yang, S. (2021) · Nutrients · doi:10.3390/nu13082788 · Cited by 13
Influence of Prior Nicotine and Alcohol Use on Functional Outcome in Patients after Intracerebral Hemorrhage
Sembill, J. A., Sprügel, M. I., Gerner, S. T., Beuscher, V. D., Giede-Jeppe, A., Stocker, M., Hoelter, P., Lücking, H., Kuramatsu, J. B., & Huttner, H. B. (2017) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2017.10.029 · Cited by 13
Alcoholic and Nonalcoholic Fatty Liver Disease and Incident Hospitalization for Liver and Cardiovascular Diseases
Chang, Y., Cho, J., Cho, Y. K., Cho, A., Hong, Y. S., Zhao, D., Ahn, J., Sohn, C. I., Shin, H. C., Güallar, E., et al. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.05.004 · Cited by 13
Alcohol‐Associated Liver Disease: East Versus West
Charatcharoenwitthaya, P., Liangpunsakul, S., & Piratvisuth, T. (2020) · Clinical Liver Disease · doi:10.1002/cld.920 · Cited by 13
Effects of Early Life Oral Arsenic Exposure on Intestinal Tract Development and Lipid Homeostasis in Neonatal Mice: Implications for NAFLD Development
Yang, X., Weber, A. A., Mennillo, E., Secrest, P., Chang, M. W., Wong, S., Le, S., Liu, J., Benner, C. W., Karin, M., et al. (2023) · Environmental Health Perspectives · doi:10.1289/ehp12381 · Cited by 12
Possibilities and limits of modelling of long-range economic consequences of air pollution – A case study
Lakner, Z., Popp, J., Oláh, J., Zéman, Z., & Molnár, V. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e26483 · Cited by 15
Metallofullerenol alleviates alcoholic liver damage via ROS clearance under static magnetic and electric fields
Wang, H., Zhao, J., Ji, S., Liu, T., Cheng, Z., Huang, Z., Zang, Y., Chen, J., Zhang, J., & Ding, Z. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.05.003 · Cited by 12

Authors: Rehm, J., Samokhvalov, A. V., & Shield, K. D.
Affiliations: Centre for Addiction and Mental Health (CA)
ORCID: Rehm, Jürgen
Samokhvalov, Andriy V.
Shield, Kevin D.
Venue: Journal of Hepatology
Publisher: Elsevier BV
Published: 2013-07
Volume: 59
Issue: 1
Pages: 160-168
ISSN: 0168-8278 (ISSN-L)
DOI: 10.1016/j.jhep.2013.03.007
OpenAlex: W2048180954
Cited by: 740
References: 59
Citations by year: 2026: 25 · 2025: 47 · 2024: 42 · 2023: 53 · 2022: 67 · 2021: 61 · 2020: 89 · 2019: 76 · 2018: 74 · 2017: 73 · 2016: 50 · 2015: 55 · 2014: 23 · 2013: 4
FWCI: 6.45
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc-nd
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 15 d)
Locations: Journal of Hepatology (publishedVersion, cc-by-nc-nd)
PubMed (publishedVersion)
Funders: Ontario Ministry of Health and Long-Term Care
Canadian Institutes of Health Research
Topics: Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Global Public Health Policies and Epidemiology
Keywords: alcoholic liver disease, liver cirrhosis, liver cancer, disability-adjusted life years, alcohol consumption, attributable fraction, alcohol taxation, global burden of disease
MeSH terms: Alcohol Drinking, Female, Humans, Liver Cirrhosis, Alcoholic, Liver Diseases, Alcoholic, Liver Neoplasms, Male, Risk Factors, Sex Factors, Global Health, Quality-Adjusted Life Years

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Global burden of alcoholic liver diseases

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks